↓ Skip to main content

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF

Overview of attention for article published in Cardiovascular Diabetology, January 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
Published in
Cardiovascular Diabetology, January 2021
DOI 10.1186/s12933-020-01208-z
Pubmed ID
Authors

David Bode, Lukas Semmler, Paulina Wakula, Niklas Hegemann, Uwe Primessnig, Nicola Beindorff, David Powell, Raphael Dahmen, Hartmut Ruetten, Christian Oeing, Alessio Alogna, Daniel Messroghli, Burkert M. Pieske, Frank R. Heinzel, Felix Hohendanner

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 13%
Student > Ph. D. Student 11 12%
Other 5 6%
Student > Master 5 6%
Student > Bachelor 4 4%
Other 14 16%
Unknown 38 43%
Readers by discipline Count As %
Medicine and Dentistry 26 29%
Biochemistry, Genetics and Molecular Biology 5 6%
Business, Management and Accounting 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Agricultural and Biological Sciences 2 2%
Other 11 12%
Unknown 39 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2022.
All research outputs
#6,952,116
of 22,797,621 outputs
Outputs from Cardiovascular Diabetology
#444
of 1,377 outputs
Outputs of similar age
#175,037
of 498,941 outputs
Outputs of similar age from Cardiovascular Diabetology
#16
of 44 outputs
Altmetric has tracked 22,797,621 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,377 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 498,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.